The College of Optometrists

do we need to report adverse effects like corneal deposits from amiodarine?! been lookin at MHRA site and got confused!

Also can we issue px with signed order to be dispensed at pharmacy for our exempt POM even when its NOT an emergency?!

read the optoms' formulary for details on the yellow card scheme. its a well-known adverse effect so i don't see what benefit yr report to the MCA will have! a letter to the GP might be in order esp. if vision's affected.

the definitions of the legal categories are very much in black and white so i don't see how you can come up with such a question. there is an ongoing debate with regards to ocular therapeutics but that is out of your league at the moment.

Px with amiodarone are often checked every year for corneal changes. Report these to gp and monitor.

Why are patients with Amiodarone keratopathy checked annually?

The corneal deposits rarely cause a problem - and even if they do, the management of the arrhythmia is more important than the keratopathy.

'cos it says that in bnf - if I remember correctly. I can't understand either why that should be.

Amiodarone can lead to optic neuropathy so good idea to check every year for that?

If they are taking a new drug, as well as amiodarone, any side effects have to be listed along with a list of current meds, I think.

Hi, Alomide is Pharmacy medication (P) that can therefore be prescribed by Optometrists in the course of their professional practice. However, it is also on the level 2 list for Opotoms with further training. Is this a bit ambiguous? Can we prescribe it if we don't have the further training? J

With regards to Alomide, I think the classification depends on quantity and concentration.

eg Sodium Cromoglicate 2.0% is POM unless sold in 10ml or less in which case it is a P medicine.